Clinical implications of epithelial cell plasticity in cancer progression
Luís Antón Aparicio(Universidade da Coruña), Angélica Figueroa(Universidade da Coruña), M. Blanco(Hospital Universitari de Girona Doctor Josep Trueta), Ángel Concha(Hospital Universitario Virgen de las Nieves), Manuel Valladares(American Society of Clinical Oncology), Raquel Castosa(Universidade da Coruña), Lourdes Calvo(Complexo Hospitalario Universitario A Coruña)
Cited by 49
Related Papers
Cancer drug resistance induced by EMT: novel therapeutic strategies
|Archives of Toxicology|2021|220
First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study
|The Oncologist|2012|213
The clinical–DWI mismatch
|Neurology|2004|207
Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy
|International Journal of Endocrinology|2010|175
Predicting response and survival in chemotherapy-treated triple-negative breast cancer
|British Journal of Cancer|2014|113